Product Details
| Product Name:
Delequamine |
CAS No.:
119905-05-4 |
| Purity:
99.39% |
Supply Ability:
10g |
| Release date:
2025/12/09 |
Product Introduction
Bioactivity
| Name | Delequamine |
| Description | Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | α2 adrenergic receptor | AdrenergicReceptor | Adrenergic Receptor |
| Inhibitors Related | Trifluoperazine dihydrochloride | Mirtazapine | Phosphorylcholine chloride | Octopamine hydrochloride | Gemfibrozil | Buflomedil hydrochloride | Dexmedetomidine hydrochloride | Isoprenaline hydrochloride | D-Mannitol | Mianserin hydrochloride | Trazodone hydrochloride | Atenolol |
| Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:259870-32-1
$36.00 / 1mg
-
CAS:896466-04-9
$35.00 / 2mg
-
CAS:112-39-0
$29.00 / 1mL
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$0.00/1removed |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 |
United States